4-Chloro-2-(trifluoromethyl)nicotinic acid, 95.0%, 5g

5-BROMO-2-ETHOXYISONICOTINIC ACID, 95.0%, 1g

2-(2-Chloro-4-isopropoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 97%, 5g

trans-m-Coumaric Acid>99.0%(GC)(T)25g

p-Bromobenzhydrol, 98.0%, 100g

1,3,5,7-TETRAAZAADAMANTANE BENZOYLGLYCINATE, 95%, 1g

Ethyl 3,3,3-Trifluoropropionate, 97.0%, 100g

1-Phenyl-1H-benzo[d]imidazol-2(3H)-one, 95.0%, 10g

(R)-tert-butyl 4-(4-(6-amino-5-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)pyridin-3-yl)-1H-pyrazol-1-yl)piperidine-1-carboxylate, 98%, 1g

CataCXium A Pd G3, ?98.0%, 100mg

SPADNS, pa, ACS, 10 g, envase de vidrio

4-(Naphthalen-2-yl)-N-phenylaniline>98.0%(GC)1g

4-Methoxymethyl-piperidine, 95.0%, 5g